Clinical Trials Sponsored by BioLite, Inc.

Total 35447 results

BioLite, Inc.

Not yet recruiting

A Study of BLEX 404 Oral Liquid in Patients With International Prognostic Scoring System (IPSS) Intermediate-1, Intermediate-2 or High-Risk Myelodysplastic Syndrome (MDS) and Chronic Myelomonocytic Leukemia (CMML)

Myelodysplastic Syndrome (MDS)
BioLite, Inc.

Completed

A Study of PDC-1421 Treatment in Adult Patients With Attention-Deficit Hyperactivity Disorder (ADHD)

Attention-Deficit Hyperactivity Disorder (ADHD)

United States
BioLite, Inc.

Completed

A Dose Escalation Phase I Study of PDC-1421 Capsule Targeting in Depression

Major Depressive Disorder

Taiwan
BioLite, Inc.

Not yet recruiting

Phase I/II, Evaluate the Safety and Efficacy of BLEX 404 With Docetaxel in Patients With Advanced/Metastatic Triple Negative Breast Cancer.

Triple Negative Breast Cancer
BioLite, Inc.

Completed

A Phase II Study of PDC-1421 Capsule to Evaluate the Safety and Efficacy in Patients With Major Depressive Disorder

Major Depressive Disorder

Taiwan, United States
BioLite, Inc.
ABVC BioPharma, Inc

Suspended

PDC-1421 Treatment in Adult Patients With ADHD

Attention-Deficit Hyperactivity Disorder (ADHD)

United States, Taiwan
BioLite, Inc.
American BriVision Corporation

Not yet recruiting

A Phase I/II Study of PDC-1421 for Treating Depression in Cancer Patients

Major Depressive Disorder

United States
Biolase Inc

Completed

Perio. Maint. With Diode LBR

Chronic Periodontitis

United States
BioVie Inc.

Terminated

A Study for Evaluation of BIV201 to Reduce Ascites and Complications in Patients With Cirrhosis and Refractory Ascites

Decompensated Cirrhosis | Ascites

United States
BioVie Inc.

Completed

Continuous Infusion Terlipressin for Patients With Cirrhosis and Refractory Ascites

Cirrhosis | Ascites Hepatic

United States
Biosite

Completed

Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT II)

Heart Failure

United States
Biosite

Withdrawn

Clinical Performance Evaluation of the Cholestech LDX Cardiac hsCRP Test (CLEAR) (CLEAR)

Cardiovascular Disease

United States
Biosite

Withdrawn

Rapid Assessment of Cardiac Markers for the Evaluation of Acute Coronary Syndrome (RACE-ACS)

Acute Coronary Syndrome

United States
Biosite

Completed

User Performance Evaluation of the INRatio® Prothrombin Time (PT) Monitoring System With a New INRatio Test Strip Designed for Low Sample Volume and Heparin Insensitivity (ECLIPSE-02)

Oral Anticoagulation

United States
Biosite

Completed

Multi-Markers In the Diagnosis of Acute Coronary Syndrome (Midas 3)

Acute Coronary Syndrome

United States
Biosite

Completed

Neutrophil Gelatinase-associated Lipocalin (NGAL) Evaluation in Emergency Department (ED) All-Comers

Acute Kidney Injury

Italy
Biosite

Completed

Neutrophil Gelatinase-associated Lipcalin(NGAL): A Novel Blood Marker for Determining the Risk of Developing Contrast-Induced Nephopathy (ENCINO)

Cardiovascular Surgery With Coronary Angiography

United States
Biosite

Completed

Evaluation of Neutrophil Gelatinase-associated Lipocalin (NGAL) in Early and Evolving Acute Kidney Injury (EVOLVE)

Kidney Failure, Acute

United States, Canada
BioVie Inc.

Completed

A Phase 3 Study of NE3107 in Probable Alzheimer's Disease

Alzheimer Disease

United States
BioVie Inc.

Completed

NE3107 Activity and Safety in Patients With Parkinson's Disease Using Levodopa

Parkinson Disease

United States
Biosite

Completed

BRAIN (Biomarker Rapid Assessment of Ischemic iNjury)

Stroke | Stroke Mimic(Conditions Presenting With Stroke-like Conditions)

United States, Canada, Germany, Switzerland, United Kingdom
Biosite

Withdrawn

Multi-marker INDex for the Risk Assessment of Sepsis in the Emergency departmenT (MINDSET) (MINDSET)

Sepsis

United States
Biosite

Terminated

Rapid Assessment of Bedside BNP In Treatment of Heart Failure (RABBIT)

Heart Failure

United States
Biosite

Completed

Evaluation of the Accuracy of the INRatio Prothrombin Time (PT) Monitoring System With a New Test Strip for the Oral Anticoagulation Therapy Patient in the Presence of Heparin and Low Molecular Weight Heparin (e.g., Enoxaparin or Dalteparin) (ECLIPSE 03)

Coagulation

United States
Biosite

Completed

Neutrophil Gelatinase-Associated Lipcalin (NGAL) Evaluation Along With B-Type Natriuretic Peptide in Acutely Decompensated HF (GALLANT)

Acute Decompensated Heart Failure

United States, Netherlands, Switzerland
Biosite

Completed

Myeloperoxidase and Multi-Markers In the Diagnosis of Diagnoses of Acute Coronary Syndrome (MIDAS) - Sample Procurement

Acute Coronary Syndrome (ACS)

United States
Biosite

Completed

Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU (REAL-ICU)

Acute Kidney Injury

United States, Canada
Biosite

Completed

SHORTness of Breath In the Emergency Department (SHORTIE)

Heart Failure | Pulmonary Embolism | Acute Myocardial Infarction

United States
Biosite

Withdrawn

Evaluation of Serial Troponin and Cardiac Multimarkers at the Point of Care in the Emergency Department (ESTIMATE)

Chest Pain | Acute Coronary Syndrome | Acute Myocardial Infarction

United States
Biosite

Completed

Evaluation of the Accuracy and Precision of the INRatio® Prothrombin Time (PT) Monitoring System With New INRatio Test Strip Designed for Low Sample Volume and Heparin Insensitivity (ECLIPSE-01)

Atrial Fibrillation | Deep Vein Thrombosis | Pulmonary Embolism

United States
Biosite

Completed

Triage Now: an Observational, Prospective Multimarker Study of Biomarkers in Patients Presenting With Chest Pain

Myocardial Infarction | Acute Coronary Syndrome

Germany
Belite Bio, Inc

Recruiting

Phase 3, Randomized, Placebo-Controlled Study of Tinlarebant to Explore Safety and Efficacy in Geographic Atrophy (PHOENIX)

Geographic Atrophy

United States, Taiwan, Australia, China, United Kingdom
Belite Bio, Inc

Completed

Safety and Tolerability of Escalating Doses of BPN-14967 in Healthy Adults

Healthy Volunteers

United States
Belite Bio, Inc

Active, not recruiting

Study to Evaluate the Safety and Efficacy of Tinlarebant in the Treatment of Stargardt Disease in Adolescent Subjects Lesion(s) in Adolescent Subjects With STGD1 (DRAGON)

Stargardt Disease 1

United States, Australia, Belgium, China, France, Germany, Hong Kong, Netherlands, Switzerland, Taiwan, United Kingdom
Biotie Therapies Inc.

Terminated

Safety and Efficacy Study of Tozadenant to Treat End of Dose Wearing Off in Parkinson's Patients (TOZ-PD)

Idiopathic Parkinson's Disease

Germany, Spain, Canada, United States, Italy, Austria, Czechia
Biotie Therapies Inc.

Completed

Study to Evaluate SYN115 in Parkinson's Disease

Parkinson's Disease

United States
Biotie Therapies Inc.

Completed

Safety and Efficacy Study of SYN115 in Parkinson's Patients Using Levodopa to Treat End of Dose Wearing Off

Parkinson's Disease

Ukraine, Argentina, Romania, Canada, United States, Chile
Columbia University
Biolase Inc

Active, not recruiting

Peri-implantitis Treatment: Clinical Results of Conventional Treatment vs. the Addition of Biolase

Peri-Implantitis

United States
McGuire Institute
Biolase Inc

Completed

Controlled Study Comparing REPaiR® and MIST Therapies for Treatment of Periodontitis

Periodontal Diseases

United States
The Alfred
Biosite

Completed

Utility of Neutrophil Gelatinase-associated Lipocalin (NGAL) in Predicting Renal Impairment, Further Decompensation and Rehospitalization in Acutely Decompensated and Chronic Heart Failure Patients (ANGLE-HF)

Heart Failure

Australia
Biotie Therapies Inc.
Acorda Therapeutics

Terminated

Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease.

Idiopathic Parkinson Disease

United States, Canada, United Kingdom
Biotie Therapies Inc.
Syneos Health

Completed

Exploratory Study to Evaluate the Effect of SYN111 (Rufinamide) in Patients With Generalized Anxiety Disorder (GAD)

Generalized Anxiety Disorder

United States
Biotie Therapies Inc.
Acorda Therapeutics

Terminated

A Study to Determine the Abuse Potential of Tozadenant Relative to D-Amphetamine and Placebo When Administered Orally in Healthy, Non-Dependent, Recreational Polydrug Users

Abuse Potential

Canada
Biotie Therapies Inc.
Acorda Therapeutics

Terminated

Study to Investigate the Influence of Hepatic Insufficiency on the Pharmacokinetics of Tozadenant

Hepatic Impairment

United States
Sengkang General Hospital
Biolitec

Recruiting

RCT Comparing Conventional Haemorrhoidectomy With Laser Haemorrhoidoplasty (COHLAH)

Hemorrhoids

Singapore
Biosite
Inverness Medical Innovations

Withdrawn

Accuracy of the Pima™ CD4 Test for Enumeration of CD4+ T-Cell Counts

HIV Infections | HIV Infection | AIDS

United States
Biosite
Inverness Medical Innovations

Completed

Heart Failure (HF) Assessment With B-type Natriuretic Peptide (BNP) In The Home (HABIT)

Heart Failure

United States
Enovate Biolife Pvt Ltd

Unknown

A Randomized Double Dummy Double Blind Dose Determining Place-bo Controlled Study to Evaluate Efficacy of Investigational Product E-RH-06 at 2 Dose Levels for the Metabolic Management of Chronic or Recurrent, Non-infective Nasal Congestion With-or-without Rhinorrhea. (EB-RH-02-11)

Chronic Rhinitis

India
be Medical
Biolitec AG

Completed

Treatment of Varicose Veins With the ELVeS® Radial® 2ring Slim Fiber. Are There Limitations?

Varicose Veins

Belgium
BioFire Diagnostics, LLC
BioFire Defense LLC

Completed

Prospective Clinical Evaluation of the FilmArray® NGDS Warrior Panel

Evaluation of Test Panel

United States

3

Subscribe